Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review committee (the “Joint Communication Review Committee” or “JCRC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) representatives to the JCRC, with each representative having knowledge and expertise in the communications related to products similar to the Optioned Products and having sufficient seniority within such Party to make decisions arising within the scope of the JCRC’s responsibilities. The JCRC may change its size from time to time if agreed by consensus among its members; provided that the JCRC shall consist at all times of an equal number of representatives of each of Galapagos and Gilead. Each Party may replace its JCRC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JCRC provided notice is given to the other Party and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRC. The JCRC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRC, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC representatives.
Appears in 2 contracts
Samples: Option, License and Collaboration Agreement (Gilead Sciences Inc), Option, License and Collaboration Agreement (Galapagos Nv)
Formation; Composition. Within […***…] days after the Effective Date], the Parties shall establish a joint communications review committee to oversee and manage the Medical Affairs Activities with respect to Product(s) in the Shared Territory in accordance with the Joint Medical Affairs Plan(s) for such Product(s) and to coordinate the regulatory activities of the Parties with respect to such activities (the “Joint Communication Review Committee” or “JCRCJMAC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) [*] representatives to the JCRCJMAC, with each representative having knowledge and expertise in the communications related to working with products similar to the Optioned Products and having sufficient seniority within such the applicable Party to make decisions arising within with the scope of the JCRCJMAC’s responsibilities. The JCRC JMAC may change its size from time to time if agreed by consensus among mutual consent of its members; , provided that the JCRC JMAC shall consist at all times of an equal number of representatives of each of Galapagos Medivation and GileadAstellas. Each Party may replace its JCRC JMAC representatives at any time upon written notice to the other Party. Either Party The JMAC may invite non-members to participate in the discussions and meetings of the JCRC JMAC, provided notice is given to the other Party and that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJMAC. The JCRC JMAC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos Medivation or GileadAstellas. The initial chairperson shall be selected by […***…]Medivation. The role of the chairperson shall be to convene and preside at meetings of the JCRCJMAC and to ensure the preparation of minutes, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JMAC representatives.
Appears in 2 contracts
Samples: Collaboration Agreement (Medivation, Inc.), Collaboration Agreement (Medivation, Inc.)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall will establish a joint communications review committee to oversee the identification, Research and Development of Research Candidates, Development Candidates and Products (but not Reversion Products) in the Territory in accordance with the Research Plan(s), Early Clinical Development Plan(s) and Late Clinical Development Plan(s) for the same and to coordinate the Research and Development activities of the Parties (the “Joint Communication Review Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall will initially appoint three (3) [***] representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to Research and Development of compounds and products similar to the Optioned Research Candidates, Development Candidates and Products and having sufficient seniority within such the applicable Party to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; time, provided that the JCRC shall JDC will consist at all times of an equal number of representatives of each of Galapagos Unum and GileadSGI. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party The JDC may invite non-members to participate in the discussions and meetings of the JCRC JDC, provided notice is given to the other Party and that such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) participants have no voting authority at the JCRCJDC. The JCRC shall JDC will have a chairperson, who shall will serve for a term of one (1) year[***], and who shall will be selected alternately, on an annual basis, by Galapagos Unum or GileadSGI. The initial chairperson shall will be selected by […***…]Unum. The role of the chairperson shall will be to convene and preside at meetings of the JCRCJDC and to ensure the preparation of minutes, but the chairperson shall have has no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 2 contracts
Samples: Collaboration Agreement (Unum Therapeutics, Inc.), Collaboration Agreement (Unum Therapeutics, Inc.)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review development committee (the “Joint Communication Review Development Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products), which shall have the responsibilities set forth in Section 1.2(b). Each Party shall initially appoint three (3) representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of compounds, Molecules and products similar to the Galapagos Molecules, Galapagos Products, Optioned Molecules and Optioned Products and having sufficient seniority within such Party to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos and Gilead. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JCRC JDC provided notice is given to the other Party and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJDC, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 2 contracts
Samples: Option, License and Collaboration Agreement (Gilead Sciences Inc), Option, License and Collaboration Agreement (Galapagos Nv)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications committee to oversee Development of Licensed Product(s) in the Territory in accordance with the Development Plan(s) for the same and to coordinate the Development activities of the Parties, and review committee and discuss the Development and Manufacture of Licensed Compound and Licensed Products (the “Joint Communication Review Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of compounds and products similar to the Optioned Licensed Products and having sufficient seniority within such the applicable Party to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; , provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos and Gilead. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party The JDC may invite non-members to participate in the discussions and meetings of the JCRC JDC, provided notice is given to the other Party and that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJDC and to ensure the preparation of minutes, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 2 contracts
Samples: License and Collaboration Agreement (Galapagos Nv), License and Collaboration Agreement (Galapagos Nv)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review commercialization committee (the “Joint Communication Review Commercialization Committee” or “JCRCJCC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Commercialization of Optioned Products). Each Party shall initially appoint three (3) representatives to the JCRCJCC, with each representative having knowledge and expertise in the communications related to commercialization of products similar to the Optioned Products and having sufficient seniority within such Party to make decisions arising within the scope of the JCRCJCC’s responsibilities. The JCRC JCC may change its size from time to time if agreed by consensus among its members; provided that the JCRC JCC shall consist at all times of an equal number of representatives of each of Galapagos and Gilead. Each Party may replace its JCRC JCC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JCRC JCC provided notice is given to the other Party and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJCC. The JCRC JCC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJCC, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JCC representatives.
Appears in 2 contracts
Samples: Option, License and Collaboration Agreement (Gilead Sciences Inc), Option, License and Collaboration Agreement (Galapagos Nv)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review committee to oversee Development of Product(s) in the Territory in accordance with the Joint Development Plan(s) for such Product(s) and to coordinate the Development activities of the Parties (the “Joint Communication Review Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) [*] representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of products similar to the Optioned Products and having sufficient seniority within such the applicable Party to make decisions arising within with the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; by[*] of [*], provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos Medivation and GileadAstellas. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party The JDC may invite non-members to participate in the discussions and meetings of the JCRC JDC, provided notice is given to the other Party and that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos Medivation or GileadAstellas. The initial chairperson shall be selected by […***…]Medivation. The role of the chairperson shall be to convene and preside at meetings of the JCRCJDC and to ensure the preparation of minutes, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 1 contract
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review committee to oversee Development of Product(s) in the Territory in accordance with the Joint Development Plan(s) for such Product(s) and to coordinate the Development activities of the Parties (the “Joint Communication Review Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) [*] representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of products similar to the Optioned Products and having sufficient seniority within such the applicable Party to make decisions arising within with the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; [*] of [*], provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos Medivation and GileadAstellas. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party The JDC may invite non-members to participate in the discussions and meetings of the JCRC JDC, provided notice is given to the other Party and that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos Medivation or GileadAstellas. The initial chairperson shall be selected by […***…]Medivation. The role of the chairperson shall be to convene and preside at meetings of the JCRCJDC and to ensure the preparation of minutes, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JDC representatives. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the securities and exchange commission pursuant to rule 24b-2 of the securities exchange act of 1934, as amended.
Appears in 1 contract
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review manufacturing committee (the “Joint Communication Review Manufacturing Committee” or “JCRCJMC”) to oversee publications and other public communications Manufacturing related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) representatives to the JCRCJMC, with each representative having knowledge and expertise in the communications related to clinical and commercial Manufacture of products similar to the Optioned Products and having sufficient seniority seniority, experience and authority within such Party to make act on behalf of and bind such Party with respect to decisions arising within the scope of the JCRCJMC’s responsibilities, and each JMC representative shall not be a member of any other Committee during any period when such representative is a member of the JMC. The JCRC JMC may change its size from time to time if agreed by consensus among its members; provided that the JCRC JMC shall consist at all times of an equal number of representatives of each of Galapagos Arcus and Gilead. Each Party may replace its JCRC JMC representatives at any time upon written notice to approval of the other Party, such approval not to be unreasonably conditioned, withheld or delayed. Either Party may invite non-members to participate in the discussions and meetings of the JCRC JMC provided notice is given to the other Party and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJMC. The JCRC JMC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos Arcus or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJMC, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JMC representatives.”
Appears in 1 contract
Samples: Option, License and Collaboration Agreement (Arcus Biosciences, Inc.)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review development committee (the “Joint Communication Review Development Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products), which shall have the responsibilities set forth in Section 2.2(b). Each Party shall initially appoint three (3) representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of Molecules and products similar to the Optioned Assembly Molecules and Assembly Products and having sufficient seniority within such Party to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos Assembly and Gilead. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JCRC provided notice is given to JDC with the other Party Party’s prior approval, such approval not to be unreasonably conditioned, withheld or delayed and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII XVII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos Assembly or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJDC, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 1 contract
Samples: Option, License and Collaboration Agreement (Assembly Biosciences, Inc.)
Formation; Composition. Within […***…] days after At a time determined by the Effective DateJSC, the Parties shall establish a joint communications review committee to oversee Development of Product(s) in the Territory and in China in accordance with the Development Plan(s) for such Product(s) and to coordinate the Development activities of the Parties (the “Joint Communication Review Committee” or “JCRCJDC”) and prior thereto, the JSC will be responsible for all JDC responsibilities except for the specific responsibilities it delegates to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Productsthe Core JPT as set out in Schedule G(a). Each Party shall initially appoint three (3) representatives of such Party or its Affiliates to the JCRC, with each JDC at its inception. Each representative having appointed to the JDC shall have knowledge and expertise in relevant aspects of the communications related to products similar to development of small molecule pharmaceutical products, including in the Optioned Products area of chronic kidney disease or cardiovascular or metabolic disorders and having sufficient seniority within such the applicable Party or Affiliate to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among mutual consent of its members; , provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos FibroGen and GileadAstraZeneca. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party The JDC may invite non-members (including consultants and advisors of a Party who are under an obligation of confidentiality consistent with this Agreement) to participate in the discussions and meetings of the JCRC JDC, provided notice is given to the other Party and that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairpersontwo (2) co-chairmen, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]XxxxxXxx and one selected by AstraZeneca. The role of the chairperson co- chairmen shall be to convene and preside at meetings of the JCRCJDC, but the chairperson they shall have no additional powers or rights beyond those held by the other JCRC JDC representatives. Each Party shall appoint a secretariat to the JDC.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement
Formation; Composition. Within […***…] days after At a time determined by the Effective DateJSC, the Parties shall establish a joint communications review committee to oversee Development of Product(s) in the Territory and in China in accordance with the Development Plan(s) for such Product(s) and to coordinate the Development activities of the Parties (the “Joint Communication Review Committee” or “JCRCJDC”) and prior thereto, the JSC will be responsible for all JDC responsibilities except for the specific responsibilities it delegates to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Productsthe Core JPT as set out in Schedule G(a). Each Party shall initially appoint three (3) representatives of such Party or its Affiliates to the JCRC, with each JDC at its inception. Each representative having appointed to the JDC shall have knowledge and expertise in relevant aspects of the communications related to products similar to development of small molecule pharmaceutical products, including in the Optioned Products area of chronic kidney disease or cardiovascular or metabolic disorders and having sufficient seniority within such the applicable Party or Affiliate to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among mutual consent of its members; , provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos FibroGen and GileadAstraZeneca. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party The JDC may invite non-members (including consultants and advisors of a Party who are under an obligation of confidentiality consistent with this Agreement) to participate in the discussions and meetings of the JCRC JDC, provided notice is given to the other Party and that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairpersontwo (2) co-chairmen, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]FibroGen and one selected by AstraZeneca. The role of the chairperson co-chairmen shall be to convene and preside at meetings of the JCRCJDC, but the chairperson they shall have no additional powers or rights beyond those held by the other JCRC JDC representatives. Each Party shall appoint a secretariat to the JDC.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Fibrogen Inc)
Formation; Composition. Within No later than […***…] days after months prior to the Effective Dateanticipated first commercial launch in the Shared Territory of the first Joint Product (or by such other date as mutually agreed by the Parties), the Parties shall establish a joint communications review commercialization committee (the “Joint Communication Review Commercialization Committee” or “JCRCJCC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products)Commercialization of Joint Products in the Shared Territory. Each Party shall initially appoint three (3) representatives to the JCRCJCC, with each representative having knowledge and expertise in the communications related to commercialization of products similar to the Optioned Joint Products and having sufficient seniority within such Party to make decisions arising within the scope of the JCRCJCC’s responsibilities. The JCRC JCC may change its size from time to time if agreed by consensus among its members; provided that the JCRC JCC shall consist at all times of an equal number of representatives of each of Galapagos Arcus and Gilead. Each Party may replace its JCRC JCC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JCRC provided notice is given to JCC with the other Party Party’s prior approval, such approval not to be unreasonably conditioned, withheld or delayed and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJCC. The JCRC JCC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJCC, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JCC representatives.
Appears in 1 contract
Samples: Option, License and Collaboration Agreement (Arcus Biosciences, Inc.)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review development committee (the “Joint Communication Review Development Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products), which shall have the responsibilities set forth in Section 2.2(b). Each Party shall initially appoint three (3) representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of Molecules and products similar to the Arcus Molecules, Arcus Products, Optioned Molecules and Optioned Products and having sufficient seniority within such Party to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos Arcus and Gilead. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JCRC provided notice is given to JDC with the other Party Party’s prior approval, such approval not to be unreasonably conditioned, withheld or delayed and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos Arcus or Gilead. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJDC, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 1 contract
Samples: Option, License and Collaboration Agreement (Arcus Biosciences, Inc.)
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review committee to coordinate the Development activities (including the related regulatory activities) of the Parties related to the Development of Licensed Compound in accordance with the Joint Development Plan (the “Joint Communication Review Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) [**] representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of compounds and products similar to Licensed Compound and the Optioned Licensed Products and having sufficient seniority within such the applicable Party to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its memberstime; provided provided, that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos and GileadParty. Each Party may replace any of its JCRC JDC representatives with a qualified employee of such Party at any time upon written notice to the other Party. Either Party The JDC may invite non-members to participate in the discussions and meetings of the JCRC provided notice is given to the other Party and JDC; provided, that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC and shall be bound by the confidentiality obligations no less stringent than those provided in this Agreement. The JCRC JDC shall have a chairpersontwo (2) co-chairpersons, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by […***…]from each Party. The role of the chairperson co-chairpersons shall be to convene and preside at meetings of such JDC. The Alliance Manager shall work with the JCRC, but co-chairpersons to prepare and circulate agendas and to ensure the chairperson preparation of minutes. The co-chairpersons shall have no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 1 contract
Formation; Composition. Within […***…] days after the Effective Date, the Parties shall establish a joint communications review committee to coordinate the Development activities of the Parties related to the Development of the Lead Compound in accordance with the Development Plan and, subject to Section 3.13, the Development of a Second Generation RET Compound or a Lead Backup in accordance with a Second Generation Research Plan (the “Joint Communication Review Committee” or “JCRCJDC”) to oversee publications and other public communications related to Optioned Programs (including Optioned Molecules and Optioned Products). Each Party shall initially appoint three (3) [***] representatives to the JCRCJDC, with each representative having knowledge and expertise in the communications related to development of compounds and products similar to the Optioned Compounds and Licensed Products and having sufficient seniority within such the applicable Party to make decisions arising within the scope of the JCRCJDC’s responsibilities. The JCRC JDC may change its size from time to time if agreed by consensus among its members; time, provided that the JCRC JDC shall consist at all times of an equal number of representatives of each of Galapagos BPM and GileadRoche. Each Party may replace its JCRC JDC representatives at any time upon written notice to the other Party. Either Party In addition, JDC members may be represented at any meeting by another person designated by the absent member who has the required expertise (which such designee shall have voting authority at the JDC for the applicable meeting). The JDC may invite non-members to participate in the discussions and meetings of the JCRC JDC, provided notice is given to the other Party and that such non-members participants shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JCRCJDC. The JCRC JDC shall have a chairperson, who shall serve for a term of one (1) year, and chairperson who shall be selected alternately, on an annual basis, by Galapagos BPM or GileadRoche. The initial chairperson shall be selected by […***…]. The role of the chairperson shall be to convene and preside at meetings of the JCRCJDC and to ensure the preparation of minutes, but the chairperson shall have no additional powers or rights beyond those held by the other JCRC JDC representatives.
Appears in 1 contract